Highlife sas
WebJan 18, 2024 · French medical technology company HighLife SAS has raised 32 million euros ($36.4 million) in an equity financing round. U.S. Venture Partners, a venture capital … WebManagement is terrible throughout the company. They show zero respect to their employees. Their attitude is " We can always find someone else." It is a revolving door of …
Highlife sas
Did you know?
WebJan 18, 2024 · French medical technology company HighLife SAS has raised 32 million euros ($36.4 million) in an equity financing round. U.S. Venture Partners, a venture capital investment firm, and French private equity firm Andera Partners co-led the Series B round with participation from Canda's Sectoral Asset Management. WebOct 30, 2024 · PARIS-- ( BUSINESS WIRE )-- HighLife SAS, an early-stage medtech company focused on the development of a unique trans-catheter mitral valve replacement (TMVR) system to treat patients suffering...
WebNov 26, 2012 · Highlife SAS is an early-stage company working on the development of transcatheter mitral valve replacement technologies. The minority investment by the Sorin … http://www.highlifemedical.com/
WebDec 21, 2024 · HighLife SAS was established in 2010 and is headquartered in Paris, France, with offices in Irvine ( California ). It is focused on the development of a novel transeptal … WebJul 23, 2024 · Feasibility Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk The safety and scientific validity of this study is the responsibility of the study sponsor and investigators.
WebThe HighLife Mitral Valve Replacement System consists of two components, a valve prosthesis and a ring shaped Sub-Annular Implant (SAI). The valve self-centers and aligns itself upon delivery inside the SAI ring surrounding it, thus allowing an easy and safe delivery. Respects the Anatomy
WebOct 31, 2024 · HighLife SAS, an early-stage medtech company focused on the development of a unique trans-catheter mitral valve replacement (TMVR) system to treat patients suffering from mitral regurgitation, announced today the closing of a € 12.3 million investment round led by Sofinnova Partners which becomes the main investor in the … philips tv auto turn onWebJan 14, 2024 · Study Design Study Type: Interventional Anticipated Enrollment : 15 participants Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment Official Title: An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System philips tv apps hinzufügenWebMar 1, 2024 · HighLife SAS (Sponsor) Clinical Trials, 4 Results, Page 1. At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. try bing chat aiWebNov 26, 2012 · Every year, over one million patients are treated with Sorin Group devices in more than 80 countries. About HighLife HighLife SAS, based in Paris, France, is an early-stage company focused on the development of a novel transcatheter replacement system for treating mitral regurgitation. philips tv app downloadphilips tv app storeWebJan 18, 2024 · Paris-based HighLife SAS is a medtech company developing a treatment for patients suffering from mitral regurgitation – a serious heart condition in which blood leaks backwards through the mitral valve each time the left ventricle contracts. Left untreated, the condition can lead to arrhythmias and heart failure. HighLife has been developing a … philips tv bowers \u0026 wilkinsWebMay 17, 2024 · Treatment. Official Title: HighLife TSMVR Feasibility Study of the Open Cell CLARITY Valve in Patients With Moderate-severe or Severe MR, High Surgical Risk and … philips tv blinking red light